Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | LAP3 | P28838 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | ECE1 | P42892 | 2/20 | 0.49 |
| ▸ | MME | P08473 | 3/20 | 0.46 |
| ▸ | LTA4H | P09960 | 1/20 | 0.46 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.46 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL23404094 | 0.98 | ALDH1A1 (0.51) | ALDH1A1MAPTLAP3MEN1LMNA | |
| SCHEMBL29816210 | 0.97 | ALDH1A1 (0.50) | ALDH1A1MAPTLAP3MEN1LMNA | |
| SCHEMBL30611018 | 0.94 | ALDH1A1 (0.47) | ALDH1A1MAPTLAP3MEN1LMNA | |
| SCHEMBL29493333 | 0.93 | MME (0.51) | ALDH1A1MAPTLAP3MEN1LMNA | |
| SCHEMBL29350546 | 0.93 | MME (0.48) | ALDH1A1MAPTLAP3MEN1LMNA | |
| SCHEMBL30582617 | 0.91 | MME (0.49) | ALDH1A1MAPTLAP3MEN1LMNA | |
| SCHEMBL29798316 | 0.91 | BACE1 (0.52) | ALDH1A1MAPTLAP3ECE1 | |
| SCHEMBL29531766 | 0.90 | BACE1 (0.46) | ALDH1A1MAPTLAP3MEN1LMNA | |
| SCHEMBL31320967 | 0.90 | FOLH1 (0.48) | ALDH1A1MAPTLAP3MEN1LMNA | |
| SCHEMBL29640269 | 0.90 | ECE1 (0.56) | ALDH1A1MAPTLAP3MEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025109003-A1 | P-CADHERIN LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2025-05-30 | — | — | WO | claimed |
| US-12050228-B2 | Automated sample quality assessment | METABOLON, INC. (US) | 2024-07-30 | — | — | US | claimed |
| WO-2024132726-A1 | SERUM PEPTIDE PATTERNS FOR DIAGNOSTICS OF ACUTE ISCHEMIC STROKE IN HUMANS AND DIFFERENTIAL DIAGNOSIS OF ACUTE ISCHEMIC STROKE FROM INTRACRANIAL HEMORRHAGIC STROKE | UNIWERSYTET GDANSKI (PL) | 2024-06-27 | — | — | WO | claimed |
| CN-117815402-A | Coupling medicine of targeting STAT3 protein and application thereof | 国家纳米科学中心 | 2024-04-05 | — | — | CN | claimed |
| US-20210088539-A1 | AUTOMATED SAMPLE QUALITY ASSESSMENT | METABOLON, INC. | 2021-03-25 | — | — | US | claimed |
| US-10890592-B2 | Automated sample quality assessment | METABOLON, INC. (US) | 2021-01-12 | — | — | US | claimed |
| EP-3478121-A1 | METHOD FOR SAMPLING GINGIVAL METABOLITES | The Procter and Gamble Company (US) | 2019-05-08 | — | — | EP | claimed |
| US-20180275144-A1 | DIAGNOSTIC TOOLS FOR ALZHEIMER'S DISEASE | PHARNEXT (FR) | 2018-09-27 | — | — | US | claimed |
| US-9964472-B2 | Methods for sampling gingival metabolites | THE PROCTER & GAMBLE COMPANY (US) | 2018-05-08 | — | — | US | claimed |
| US-20180003598-A1 | METHODS FOR SAMPLING GINGIVAL METABOLITES | THE PROCTER & GAMBLE COMPANY | 2018-01-04 | — | — | US | claimed |
| WO-2018005335-A1 | METHOD FOR SAMPLING GINGIVAL METABOLITES | THE PROCTER & GAMBLE COMPANY (US) | 2018-01-04 | — | — | WO | claimed |
| WO-2016124574-A1 | DIAGNOSTIC TOOLS FOR ALZHEIMER'S DISEASE | PHARNEXT (FR) | 2016-08-11 | — | — | WO | claimed |
| EP-3481849-B1 | CHIMERIC DENGUE/ZIKA VIRUSES AS LIVE-ATTENUATED ZIKA VIRUS VACCINES | US HEALTH (US) | 2025-12-10 | — | — | EP | disclosed |
| CN-120005928-A | Dynamic regulation and control system, strain, construction method of strain and application of strain in microbial fuel cell | 天津科技大学 | 2025-05-16 | — | — | CN | disclosed |
| US-20250025520-A1 | MICROBE-BASED MODULATION OF SEROTONIN BIOSYNTHESIS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2025-01-23 | — | — | US | disclosed |
| CN-112313238-B | Tetrahydropyranoxazine derivatives with selective BACE1 inhibiting activity | 盐野义制药株式会社 | 2025-01-17 | — | — | CN | disclosed |
| US-20150293072-A1 | METHODS AND SYSTEMS FOR DETERMINING AUTISM SPECTRUM DISORDER RISK | LABORATORY CORPORATION OF AMERICA HOLDINGS | 2015-10-15 | — | — | US | disclosed |
| EP-0476022-A1 | CRYSTALLINE R-H-GM-CSF AND METHOD FOR THE PREPARATION | SCHERING CORPORATION (US) | 1992-03-25 | — | — | EP | disclosed |
| WO-1990015151-A1 | CRYSTALLINE R-H-GM-CSF AND METHOD FOR THE PREPARATION | SCHERING CORPORATION (US) | 1990-12-13 | — | — | WO | disclosed |
| EP-0402070-A1 | Crystalline r-h-GM-CSF and method for its preparation | SCHERING CORPORATION (US) | 1990-12-12 | — | — | EP | disclosed |